Use of convalescent plasma in COVID ‐19 patients with immunosuppression-Reference-Cited by-同舟云学术

Use of convalescent plasma in COVID ‐19 patients with immunosuppression

Published:2021-06 Issue:8 Volume:61 Page:2503-2511
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Senefeld Jonathon W.¹^ORCID,Klassen Stephen A.¹,Ford Shane K.¹,Senese Katherine A.¹,Wiggins Chad C.¹,Bostrom Bruce C.²,Thompson Michael A.³,Baker Sarah E.¹,Nicholson Wayne T.¹,Johnson Patrick W.⁴,Carter Rickey E.⁴,Henderson Jeffrey P.⁵,Hartman William R.⁶^ORCID,Pirofski Liise‐anne⁷,Wright R. Scott⁸,Fairweather De Lisa⁹,Bruno Katelyn A.⁹,Paneth Nigel S.¹⁰,Casadevall Arturo¹¹,Joyner Michael J.¹

Affiliation:

1. Department of Anesthesiology and Perioperative Medicine Mayo Clinic Rochester Minnesota USA

2. Pediatric Oncology and Hematology, Children's Hospital of Minnesota Minneapolis Minnesota USA

3. Aurora Cancer Care, Advocate Aurora Health Milwaukee Wisconsin USA

4. Department of Health Sciences Research, Mayo Clinic Jacksonville Florida USA

5. Division of Infectious Diseases, Department of Medicine Washington University School of Medicine St. Louis Missouri USA

6. Department of Anesthesiology University of Wisconsin‐Madison School of Medicine and Public Health Madison Wisconsin USA

7. Division of Infectious Diseases, Department of Medicine Albert Einstein College of Medicine Bronx New York USA

8. Department of Cardiovascular Medicine and Director Human Research Protection Program Mayo Clinic Rochester Minnesota USA

9. Department of Cardiovascular Medicine Mayo Clinic Jacksonville Florida USA

10. Department of Epidemiology and Biostatistics and Department of Pediatrics and Human Development Michigan State University East Lansing Michigan USA

11. Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA

Funder

Natural Sciences and Engineering Research Council of Canada

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16525

Reference107 articles.

1. The convalescent sera option for containing COVID-19

2. Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19

3. Deployment of convalescent plasma for the prevention and treatment of COVID-19

4. US Food and Drug Administration.Clinical memorandum for the emergency use authorization of COVID‐19 convalescent plasma 2020.

5. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13

2. Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19;mBio;2024-05-08

3. Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial;Transfusion;2024-03-21

4. Convalescent Plasma for Immunocompromised Patients;Current Topics in Microbiology and Immunology;2024

5. Convalescent Plasma and the US Expanded Access Program: A Personal Narrative;Current Topics in Microbiology and Immunology;2024